Literature DB >> 3778479

Evidence for direct binding of Clostridium botulinum type E derivative toxin and its fragments to gangliosides and free fatty acids.

Y Kamata, S Kozaki, G Sakaguchi, M Iwamori, Y Nagai.   

Abstract

Clostridium botulinum type E derivative toxin and its heavy chain bound to gangliosides GT1b, GD1a and GQ1b and saturated and unsaturated free fatty acids with chain lengths of 14-20 carbons. The L-H-1 fragment lacking the carboxyl-terminal portion of the heavy chain bound to free fatty acids but not to gangliosides. These observations led us to a new hypothesis on the mechanism of binding between botulinum toxin and gangliosides; the carboxyl-terminal portion (H-2 fragment) of the heavy chain binds to an oligosaccharide residue of gangliosides and then the amino-terminal portion (H-1 fragment) interacts with the hydrophobic portion of gangliosides consisting of fatty acids.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3778479     DOI: 10.1016/0006-291x(86)90736-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Antigenic structure of Clostridium botulinum type B neurotoxin and its interaction with gangliosides, cerebroside, and free fatty acids.

Authors:  S Kozaki; J Ogasawara; Y Shimote; Y Kamata; G Sakaguchi
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

2.  Effect of pH on the interaction of botulinum neurotoxins A, B and E with liposomes.

Authors:  C Montecucco; G Schiavo; B R Dasgupta
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

Review 3.  Receptor mimicry as novel therapeutic treatment for biothreat agents.

Authors:  Richard J Thomas
Journal:  Bioeng Bugs       Date:  2010 Jan-Feb

4.  Anti-GT1a IgG in Guillain-Barré syndrome.

Authors:  M Koga; H Yoshino; M Morimatsu; N Yuki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

Review 5.  Glycosphingolipids-sweets for botulinum neurotoxin.

Authors:  Brian C Yowler; Cara-Lynne Schengrund
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

6.  Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons.

Authors:  Min Dong; Huisheng Liu; William H Tepp; Eric A Johnson; Roger Janz; Edwin R Chapman
Journal:  Mol Biol Cell       Date:  2008-09-24       Impact factor: 4.138

7.  Interaction of botulinum and tetanus toxins with the lipid bilayer surface.

Authors:  C Montecucco; G Schiavo; Z Gao; E Bauerlein; P Boquet; B R DasGupta
Journal:  Biochem J       Date:  1988-04-15       Impact factor: 3.857

8.  Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors.

Authors:  Lisheng Peng; William H Tepp; Eric A Johnson; Min Dong
Journal:  PLoS Pathog       Date:  2011-03-31       Impact factor: 6.823

9.  Botulinum neurotoxins B and E translocate at different rates and exhibit divergent responses to GT1b and low pH.

Authors:  Shihu Sun; William H Tepp; Eric A Johnson; Edwin R Chapman
Journal:  Biochemistry       Date:  2012-07-02       Impact factor: 3.162

Review 10.  Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics.

Authors:  Jonathan R Davies; Sai Man Liu; K Ravi Acharya
Journal:  Toxins (Basel)       Date:  2018-10-20       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.